Related Experiment Video
Updated: Jul 8, 2026

07:32
Measuring Maxillary Posterior Tooth Movement: A Model Assessment using Palatal and Dental Superimposition
Published on: February 23, 2024
Vertical changes in treated and untreated Class II division 1 malocclusions
Craig Sharp1, Michael Harkness, Peter Herbison
1csharp@ortho1.co.nz
Summary
Orthodontic treatment for Class II division 1 malocclusion in girls did not show lasting effects on molar or face height. Increases observed during treatment were not significantly different from natural growth in the control group.
Area of Science:
- Orthodontics
- Craniofacial growth
- Cephalometric analysis
Background:
- Treatment-induced facial height increases may be permanent.
- Understanding long-term effects of orthodontic treatment on craniofacial dimensions is crucial.
Purpose of the Study:
- To determine if appliance-induced increases in molar heights and facial height are maintained in girls with Class II division 1 malocclusion.
- To compare long-term changes in treated versus untreated individuals.
Main Methods:
- Lateral cephalometric radiographs of 11-year-old girls with treated (Begg appliance and Class II elastics) and untreated Class II division 1 malocclusions were analyzed.
- Measurements included 10 angles and 10 distances, with initial and recall records averaged 12 years apart for the treatment group and 8 years for the control group.
Main Results:
- Both groups showed significant increases in upper and lower molar heights and anterior face height (AFH) over time.
- At recall, AFH was significantly greater in the treatment group, attributed to initial differences, longer follow-up, and less variation.
- No significant differences in overjet or upper incisor inclination were found at recall; SNA and SNB angles were smaller in the treatment group.
Conclusions:
- Molar and facial heights increased in both treated and untreated groups.
- Orthodontic treatment with the Begg appliance and Class II elastics may not have lasting effects on facial or molar height in this patient group.